White Paper

Human Factors Considerations For Combination Products

By Ana Ladino

Human Factors Considerations For Combination Products

In February of 2016, the FDA released a draft guidance regarding Human Factors and Related Clinical Study Considerations in Combination Product Design and Development. This paper highlights the human factors studies in the development in combination products, clarifies the difference between the studies, and discusses how the studies are part of the process to maximize the likelihood that the combination product user interface is safe and effective for use by the intended users, uses, and environments.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

West Pharmaceutical Services, Inc.